Ultragenyx Pharmaceutical (RARE) Gets a Buy from Piper Sandler
Piper Sandler analyst Allison Bratzel maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) today and set a price ...
Piper Sandler Reaffirms Their Buy Rating on BioMarin Pharmaceutical (BMRN)
In a report released today, Allison Bratzel from Piper Sandler maintained a Buy rating on BioMarin Pharmaceutical (BMRN – Research Report), ...
AstraZeneca Seals Deal For EsoBiotec To Advance Cell Therapy: Details
AstraZeneca PLC has agreed to acquire EsoBiotec SA, a biotech company specializing in in vivo cell therapies. The $1 billion ...
The Manila Times9h
Metagenomi Reports Business Updates and Full Year 2024 Financial Results
EMERYVILLE, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company ...
RNA Therapeutics Market is expected to generate a revenue of USD 22.37 Billion by 2032, Globally, at 9.4% CAGR: Verified Market Research®
Verified Market Research®, a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the RNA Therapeutics ...